Navigation Links
Catabasis Closes $32.4 Million Series B Financing
Date:11/14/2013

CAMBRIDGE, Mass., Nov. 15, 2013 /PRNewswire/ -- Catabasis Pharmaceuticals, Inc., today announced it has completed a $32.4 million Series B financing round led by new investor Lightstone Ventures. A leading public crossover fund and all current Catabasis investors, including SV Life Sciences, Clarus Ventures, MedImmune Ventures and Advanced Technology Ventures, also participated in the financing.

"This investment reflects our confidence in Catabasis' pipeline of SMART Linker conjugates as much as our belief in management's ability to successfully advance its clinical candidates," said Jean George, partner of Lightstone Ventures. "Catabasis has achieved a number of important milestones in the past year including positive data from Phase 1 studies of both CAT-2003 and CAT-1004. We look forward to working with the management team as they complete the ongoing Phase 2 trial for CAT-2003 and seek to advance the rest of the pipeline."

Catabasis plans to use proceeds from this financing to support the development of its lead compound, CAT-2003, a modulator of the lipid synthesis pathway, which is currently in a Phase 2 clinical trial in patients with hypertriglyceridemia and in combination with statins in patients with hypercholesterolemia. Catabasis also plans to use the proceeds to support the continued clinical and pre-clinical development of other SMART Linker conjugates in the pipeline.

"We are tremendously excited about the progress we've made with our pipeline thus far, having reported positive Phase 1 data for both CAT-2003 and CAT-1004 and having advanced CAT-2003 to Phase 2," said Jill Milne, Ph.D., co-founder and chief executive officer of Catabasis. "This financing enables Catabasis to continue to execute on the promise of its pipeline for dyslipidemias and diseases involving chronic inflammation."  '/>"/>

SOURCE Catabasis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Catabasis Initiates Phase 1 Trial of CAT-2003 for Treatment of Severe Hypertriglyceridemia
2. Catabasis Pharmaceuticals Announces Issuance of Patents for CAT-1000 and CAT-2000 Series
3. Catabasis Names Ian Sanderson Chief Financial Officer
4. Independa Closes Convertible Note Funding at $2.35 Million
5. Stereotaxis Closes $18.5 Million Private Placement Financings
6. Boston Scientific Closes Cameron Health Acquisition
7. C8 MediSensors Closes $19 million Preferred Stock Financing
8. Igenica Closes $33 Million in Series C Funding
9. BONESUPPORT Closes Second Tranche of Funding
10. PTC Therapeutics Closes $30 Million Financing
11. Chiasma Closes $38.5 Million Equity Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , August 28, 2015 ... Market by Tumor (Breast, Lung, Prostate) Type (Protein & ... (Diagnostic, Drug Discovery, Prognostic) & Geography - Global Forecast ... is expected to reach around 17,689.0 Million USD by ... period of 2015 to 2020. Browse ...
(Date:8/28/2015)... Aug. 28, 2015 ... the addition of the "12th Annual Report ... report to their offering. The ... Manufacturing Capacity and Production is the most recent ... current and projected future capacity and production. The ...
(Date:8/28/2015)... Aug. 28, 2015 Patterson Medical, formerly ... PDCO ), is now an independent company ... of Patterson Medical by Madison Dearborn Partners (MDP).  ... name for a transition period before rebranding as ... sports medicine products.  With the focused resources and ...
Breaking Medicine Technology:Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 512th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3
... 2011 The University of California, Los Angeles (UCLA) ... soon become the third oncology research center in the ... a privately held medical device company. ViewRay,s new research ... patented combination of radiotherapy delivery and simultaneous magnetic resonance ...
... Nearly three quarters of the medical ... from developed markets, but the next wave of growth is ... unique needs of the India market, according to preliminary findings ... which were presented today at AdvaMed 2011, the annual MedTech ...
Cached Medicine Technology:UCLA Health System - Jonsson Comprehensive Cancer Center to Acquire ViewRay Radiation Therapy Research System 2Made in India, for India, is Next Wave of Growth for Region's Medical Technology Sector 2Made in India, for India, is Next Wave of Growth for Region's Medical Technology Sector 3
(Date:8/31/2015)... ... August 31, 2015 , ... On Saturday, May 30th, ... at the Adams County Fairgrounds in Mendon, IL. The purpose behind this concert was ... Mendon and neighboring town, Quincy. Best Drug Rehabilitation’s sponsorship of “Music with a Mission” ...
(Date:8/31/2015)... ... August 31, 2015 , ... “My mother and husband ... inventor, from Hagerhill, Ky. “I thought there could be a comfortable way to prevent ... The Nasal Cannula Ear Protector offers a more secure way to anchor the cannula ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... medical professional association for physicians and allied health professionals dedicated to using ... Foundation, announced today the establishment of the Lifestyle Medicine Lifetime Achievement and ...
(Date:8/31/2015)... ... August 31, 2015 , ... Chicago-based ... with Bright Pink® to raise money and awareness for breast and ovarian health. ... Hot Pink Sassy incandescent Mood-lite sold to Bright Pink® to encourage households, dorms, ...
(Date:8/31/2015)... ... August 31, 2015 , ... Juvent Sports ( http://www.juvent.com ) just ... sports figures who are finding joint pain relief after using their revolutionary Micro-Impact Platform™ ... player in the world said, “For the first time in over 20 years I ...
Breaking Medicine News(10 mins):Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 3Health News:InventHelp® Inventor Designs Nasal Cannula Ear Protector (AVZ-1217) 2Health News:Nominations Sought for Awards Recognizing Exemplary Contribution to the Field of Lifestyle Medicine 2Health News:Nominations Sought for Awards Recognizing Exemplary Contribution to the Field of Lifestyle Medicine 3Health News:Mood-lites® is proud to launch “Brighten Our World" Campaign to Raise Money and Awareness for Breast and Ovarian Health Across America in Partnership with Bright Pink® 2Health News:Mood-lites® is proud to launch “Brighten Our World" Campaign to Raise Money and Awareness for Breast and Ovarian Health Across America in Partnership with Bright Pink® 3Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 2Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 3
... , THURSDAY, May 17 (HealthDay News) -- Smoking ... and 2010, but too many of them still light up, ... current cigarette use among U.S. teens decreased from nearly 12 ... dropped from nearly 40 percent to about 34 percent among ...
... patients with one of the most common causes of blindness ... partnership. Researchers from the University of Strathclyde and Stanford ... of age related macular degeneration (AMD), which affects one in ... in eight aged over 85. The device would be ...
... Mental distractions can act as a form of pain relief, ... to complete a difficult or easy memory task while a ... participants perceived less pain when they were more distracted by ... MRI, the German researchers also found that the lower levels ...
... (May 16, 2012)If racial and ethnic disparities in breast cancer ... of imaging to assess the extent of tumors before surgery, ... Chase Cancer Center researchers at the 2012 Annual Meeting of ... "It,s encouraging that we didn,t see any differences between ...
... ALEXANDRIA, Va. The American Society of Clinical Oncology ... from among more than 4,500 abstracts publicly posted online ... Plenary, late-breaking and other major studies will be ... to be held June 1-5, 2012, at McCormick Place ...
... Macmillan Survivorship Research Group (MSRG), at the University of Southampton, ... the experiences and needs of people after primary treatment of ... people are living with, or beyond, cancer in the UK, ... average over 6,000 patients are diagnosed with cancer each year ...
Cached Medicine News:Health News:Fewer Young Americans Smoking, Survey Finds 2Health News:Prosthetic retina offers simple solution to restoring sight 2Health News:Prosthetic retina offers simple solution to restoring sight 3Health News:Fox Chase researchers find no disparities in imaging before breast cancer surgery 2Health News:ASCO releases studies from upcoming annual meeting 2Health News:Researchers undertake radical new cancer survivorship study 2Health News:Researchers undertake radical new cancer survivorship study 3
... true breakthrough in ophthalmic ultrasound, offering an ... capability previously unavailable. See pathology formerly unavailable, ... up to 105db to view vitreous details ... 90db setting - or reduce it to ...
The Ultrasonic BioMicroscope (UBM P40) provides the highest ultrasound resolution for imaging....
PremierEdge Stab Knives - 45....
VISCO SHIELD Viscoelastic. Complete with 23g x 7/8" Thin Wall Cannula....
Medicine Products: